Financials DexCom, Inc.

Stocks

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX Other stock markets 02:55:39 04/08/2026 HKT			5-day change	1st Jan Change
86.91 ^USD	+4.15%		+18.03%	+30.48%

10:19pm	UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating	MT
08:46pm	Rothschild & Co Redburn Adjusts Price Target on DexCom to $100 From $90, Maintains Buy Rating	MT

Projected Income Statement: DexCom, Inc.

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net sales ¹	2,448	2,910	3,622	4,033	4,662	5,230	5,817	6,475
Change	-	18.84%	24.49%	11.34%	15.6%	12.19%	11.21%	11.31%
EBITDA ¹	472.7	751.6	1,014	1,105	1,349	1,665	1,925	2,221
Change	-	59%	34.98%	8.92%	22.05%	23.45%	15.63%	15.36%
EBIT ¹	370.7	485.1	718.6	757.1	969.3	1,248	1,454	1,727
Change	-	30.86%	48.13%	5.36%	28.03%	28.76%	16.5%	18.74%
Interest Paid ¹	-90.4	-0.4	-	109	-18.3	-12.1	-8	-8
Earnings before Tax (EBT) ¹	173.9	390.8	710.4	709	1,088	1,234	1,486	1,715
Change	-	124.73%	81.78%	-0.2%	53.51%	13.4%	20.4%	15.42%
Net income ¹	154.7	341.2	541.5	576.2	836.3	967.4	1,163	1,425
Change	-	120.56%	58.7%	6.41%	45.14%	15.68%	20.22%	22.51%
Announcement Date	10/2/22	9/2/23	8/2/24	13/2/25	12/2/26	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4	2028 Q1	2028 Q2
Net sales ¹	650.2	698.2	628.8	696.2	769.6	815.2	741.5	871.3	975	1,034	921	1,004	994.2	1,114	1,036	1,157	1,209	1,260	1,192	1,308	1,329	1,401	1,326	1,443	1,477	1,547	1,480	1,589
Change	-	7.38%	-9.94%	10.72%	10.54%	5.93%	-9.04%	17.51%	11.9%	6.1%	-10.97%	9.04%	-1.01%	12%	-6.96%	11.69%	4.51%	4.16%	-5.37%	9.77%	1.55%	5.45%	-5.38%	8.83%	2.35%	4.78%	-4.37%	7.43%
EBITDA ¹	149.3	131.1	112.4	175.5	226.6	237.1	145.9	232.6	314.5	321.5	220.9	283.9	300.1	300.1	230.4	327.6	368.4	422.2	364.5	421.3	423.3	454.8	412.9	471.3	488.8	530.7	510.1	539.8
Change	-	-12.19%	-14.26%	56.14%	29.12%	4.63%	-38.46%	59.42%	35.21%	2.23%	-31.29%	28.52%	5.71%	0%	-23.23%	42.19%	12.45%	14.6%	-13.67%	15.58%	0.48%	7.43%	-9.22%	14.15%	3.71%	8.58%	-3.89%	5.82%
EBIT ¹	123.8	99	50.3	101.9	160.8	172.1	78.6	158.4	238.9	242.7	140.2	195.4	212	209.5	143.1	221.8	272.9	331.5	264.4	328.3	313.8	343.3	297.1	356.4	370.6	413.8	383.9	410.7
Change	-	-20.03%	-49.19%	102.58%	57.8%	7.03%	-54.33%	101.53%	50.82%	1.59%	-42.23%	39.37%	8.5%	-1.18%	-31.69%	55%	23.04%	21.47%	-20.24%	24.17%	-4.42%	9.42%	-13.46%	19.94%	4%	11.65%	-7.23%	6.98%
Charge d'intérêts ¹	-23.4	-25.2	-5.2	-1.7	-1.3	7.8	17.3	31.2	33.9	-	31.4	-29.8	25.4	22.4	20.6	-4.7	-4.7	-4.2	-3.1	-	-3	-3	-2	-2	-2	-2	-	-
Earnings before Tax (EBT) ¹	90.7	-14.7	36.1	75.3	146.2	133.2	64.5	159.3	240.4	246.2	132.5	187.8	177.4	211.3	154.3	241.1	352.3	340.7	269.5	317.5	333.6	355.1	309.3	371.1	383	422.5	-	-
Change	-	-116.21%	345.58%	108.59%	94.16%	-8.89%	-51.58%	146.98%	50.91%	2.41%	-46.18%	41.74%	-5.54%	19.11%	-26.98%	56.25%	46.12%	-3.29%	-20.9%	17.81%	5.08%	6.44%	-12.9%	19.98%	3.19%	10.31%	-	-
Net income ¹	70.9	-19.4	97.3	50.9	101.2	91.8	48.6	115.9	120.7	256.3	146.4	143.5	134.6	151.7	105.4	179.8	283.8	267.3	199.5	249.1	258.8	274.4	246.9	287.8	297.2	322	340.7	347
Change	-	-127.36%	601.55%	-47.69%	98.82%	-9.29%	-47.06%	138.48%	4.14%	112.34%	-42.88%	-1.98%	-6.2%	12.7%	-30.52%	70.59%	57.84%	-5.81%	-25.36%	24.86%	3.89%	6.03%	-10.03%	16.56%	3.29%	8.33%	5.8%	1.86%
Announcement Date	28/10/21	10/2/22	28/4/22	28/7/22	27/10/22	9/2/23	27/4/23	27/7/23	26/10/23	8/2/24	25/4/24	25/7/24	24/10/24	13/2/25	1/5/25	30/7/25	30/10/25	12/2/26	30/4/26	30/7/26	-	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: DexCom, Inc.

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net Debt ¹	650	1,328	1,868	696	323	-619	-1,107	-1,860
Change	-	104.31%	40.66%	-62.74%	-53.59%	-291.52%	-78.84%	-68.02%
Announcement Date	10/2/22	9/2/23	8/2/24	13/2/25	12/2/26	-	-	-

¹USD in Million

Estimates

Cash Flow Forecast: DexCom, Inc.

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
CAPEX ¹	389.2	364.8	236.6	358.8	363.5	369.4	367.2	395
Change	-	-6.27%	-35.14%	51.65%	1.31%	1.64%	-0.62%	7.59%
Free Cash Flow (FCF) ¹	53.3	305	511.9	630.7	1,077	1,025	1,250	1,528
Change	-	472.23%	67.84%	23.21%	70.79%	-4.86%	21.96%	22.27%
Announcement Date	10/2/22	9/2/23	8/2/24	13/2/25	12/2/26	-	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: DexCom, Inc.

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	19.31%	25.83%	28.01%	27.4%	28.93%	31.86%	33.14%	34.37%
EBIT Margin (%)	15.14%	16.67%	19.84%	18.77%	20.79%	23.87%	24.96%	26.69%
EBT Margin (%)	7.1%	13.43%	19.61%	17.58%	23.35%	24.06%	24.69%	25.42%
Net margin (%)	6.32%	11.73%	14.95%	14.29%	17.94%	18.56%	19.69%	21.68%
FCF margin (%)	2.18%	10.48%	14.13%	15.64%	23.11%	19.59%	21.55%	23.65%
FCF / Net Income (%)	34.45%	89.39%	94.53%	109.46%	128.81%	105.55%	109.45%	109.09%
Profitability
ROA	5.83%	6.78%	9.29%	9.2%	13.04%	14.55%	15.06%	15.74%
ROE	13.08%	16.77%	25.78%	27.63%	34.16%	34.24%	33.26%	31.7%
Financial Health
Leverage (Debt/EBITDA)	1.38x	1.77x	1.84x	0.63x	0.24x	-	-	-
Debt / Free cash flow	12.2x	4.35x	3.65x	1.1x	0.3x	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	15.9%	12.54%	6.53%	8.9%	7.8%	7.06%	6.33%	6.11%
CAPEX / EBITDA (%)	82.34%	48.54%	23.32%	32.47%	26.95%	22.17%	19.1%	17.79%
CAPEX / FCF (%)	730.21%	119.61%	46.22%	56.89%	33.74%	36.05%	29.38%	25.85%
Items per share
Cash flow per share ¹	1.105	1.566	1.759	2.398	3.553	3.908	4.296	5.052
Change	-	41.7%	12.33%	36.3%	48.19%	9.99%	9.94%	17.6%
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	5.803	5.518	5.367	5.164	7.136	7.568	9.119	11.84
Change	-	-4.9%	-2.74%	-3.8%	38.2%	6.05%	20.5%	29.89%
EPS ¹	0.3875	0.82	1.3	1.42	2.09	2.481	2.944	3.549
Change	-	111.61%	58.54%	9.23%	47.18%	18.7%	18.68%	20.55%
Nbr of stocks (in thousands)	387,688	386,258	386,374	390,595	390,016	377,361	377,361	377,361
Announcement Date	10/2/22	9/2/23	8/2/24	13/2/25	12/2/26	-	-	-